Measurement of Self-advocacy in Cancer Patients and Survivors
Overview
Oncology
Authors
Affiliations
Background: The Patient Self-Advocacy Scale, originally developed for use in HIV/AIDS patients, was adapted for use in cancer patients and survivors. The scale contains three dimensions: increased illness education, increased assertiveness with a doctor, and potential for mindful non-adherence.
Discussion And Conclusion: Evidence for modest reliability and construct validity was found; however, ceiling effects exist for the Illness Education subscale, which supports the need to move beyond items regarding information seeking to perhaps include use and management of information.
Cui J, Wang J, Yue A, Cao J, Zhang Z, Shi B Sci Rep. 2025; 15(1):6871.
PMID: 40011690 PMC: 11865501. DOI: 10.1038/s41598-025-91129-2.
Lazris D, Donovan H, Scott P, Nilsen M, Thomas T J Cancer Educ. 2024; .
PMID: 39487933 DOI: 10.1007/s13187-024-02536-4.
Symptom Burden and Self-Advocacy: Exploring the Relationship Among Female Cancer Survivors.
Hagan T, Gilbertson-White S, Cohen S, Temel J, Greer J, Donovan H Clin J Oncol Nurs. 2018; 22(1):E23-E30.
PMID: 29350706 PMC: 5841467. DOI: 10.1188/18.CJON.E23-E30.
The Female Self-Advocacy in Cancer Survivorship Scale: A validation study.
Hagan T, Cohen S, Rosenzweig M, Zorn K, Stone C, Donovan H J Adv Nurs. 2017; 74(4):976-987.
PMID: 29117439 PMC: 5844819. DOI: 10.1111/jan.13498.
Theoretical to Tangible: Creating a Measure of Self-Advocacy for Female Cancer Survivors.
Hagan T, Cohen S, Stone C, Donovan H J Nurs Meas. 2017; 24(3):428-441.
PMID: 28714448 PMC: 5514617. DOI: 10.1891/1061-3749.24.3.428.